Patents by Inventor Vasilios Voudouris

Vasilios Voudouris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
    Publication number: 20230364017
    Abstract: Provided herein are pharmaceutical compositions comprising nitrogen mustard, for example bendamustine hydrochloride, solid dispersions substantially free of degradants. Also provided are methods of producing and administering nitrogen mustards and in particular bendamustine hydrochloride solid dispersions substantially free of degradants. The pharmaceutical compositions can be used for any disease that is sensitive to treatment with bendamustine hydrochloride, such as neoplastic diseases.
    Type: Application
    Filed: July 20, 2023
    Publication date: November 16, 2023
    Inventor: Vasilios VOUDOURIS
  • BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20230310381
    Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: May 23, 2023
    Publication date: October 5, 2023
    Inventor: Vasilios VOUDOURIS
  • Bendamustine pharmaceutical compositions
    Patent number: 11701344
    Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: July 18, 2023
    Inventor: Vasilios Voudouris
  • BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220079923
    Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: November 22, 2021
    Publication date: March 17, 2022
    Inventor: Vasilios VOUDOURIS
  • BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
    Publication number: 20210346289
    Abstract: Provided herein are pharmaceutical compositions comprising nitrogen mustard, for example bendamustine hydrochloride, solid dispersions substantially free of degradants. Also provided are methods of producing and administering nitrogen mustards and in particular bendamustine hydrochloride solid dispersions substantially free of degradants. The pharmaceutical compositions can be used for any disease that is sensitive to treatment with bendamustine hydrochloride, such as neoplastic diseases.
    Type: Application
    Filed: July 20, 2021
    Publication date: November 11, 2021
    Inventor: Vasilios VOUDOURIS
  • BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210008036
    Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: August 21, 2020
    Publication date: January 14, 2021
    Inventor: Vasilios VOUDOURIS
  • Bendamustine pharmaceutical compositions
    Patent number: 10786486
    Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: September 29, 2020
    Inventor: Vasilios Voudouris
  • Bendamustine Solid Dispersions And Continuous Infusion
    Publication number: 20180185279
    Abstract: Provided herein are pharmaceutical compositions comprising nitrogen mustard, for example bendamustine hydrochloride, solid dispersions substantially free of degradants. Also provided are methods of producing and administering nitrogen mustards and in particular bendamustine hydrochloride solid dispersions substantially free of degradants. The pharmaceutical compositions can be used for any disease that is sensitive to treatment with bendamustine hydrochloride, such as neoplastic diseases.
    Type: Application
    Filed: February 26, 2018
    Publication date: July 5, 2018
    Inventor: Vasilios Voudouris
  • BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20180071263
    Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: November 16, 2017
    Publication date: March 15, 2018
    Inventor: Vasilios Voudouris
  • Bendamustine solid dispersions and continuous infusion
    Patent number: 9907752
    Abstract: Provided herein are pharmaceutical compositions comprising nitrogen mustard, for example bendamustine hydrochloride, solid dispersions substantially free of degradants. Also provided are methods of producing and administering nitrogen mustards and in particular bendamustine hydrochloride solid dispersions substantially free of degradants. The pharmaceutical compositions can be used for any disease that is sensitive to treatment with bendamustine hydrochloride, such as neoplastic diseases.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: March 6, 2018
    Inventor: Vasilios Voudouris
  • Bendamustine pharmaceutical compositions
    Patent number: 9849115
    Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: December 26, 2017
    Inventor: Vasilios Voudouris
  • Bendamustine Solid Dispersions And Continuous Infusion
    Publication number: 20160310422
    Abstract: Provided herein are pharmaceutical compositions comprising nitrogen mustard, for example bendamustine hydrochloride, solid dispersions substantially free of degradants. Also provided are methods of producing and administering nitrogen mustards and in particular bendamustine hydrochloride solid dispersions substantially free of degradants. The pharmaceutical compositions can be used for any disease that is sensitive to treatment with bendamustine hydrochloride, such as neoplastic diseases.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 27, 2016
    Inventor: Vasilios Voudouris
  • Bendamustine solid dispersions and continuous infusion
    Patent number: 9320730
    Abstract: Provided herein are pharmaceutical compositions comprising nitrogen mustard, for example bendamustine hydrochloride, solid dispersions substantially free of degradants. Also provided are methods of producing and administering nitrogen mustards and in particular bendamustine hydrochloride solid dispersions substantially free of degradants. The pharmaceutical compositions can be used for any disease that is sensitive to treatment with bendamustine hydrochloride, such as neoplastic diseases.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: April 26, 2016
    Inventor: Vasilios Voudouris
  • Bendamustine Solid Dispersions And Continuous Infusion
    Publication number: 20150258069
    Abstract: Provided herein are pharmaceutical compositions comprising nitrogen mustard, for example bendamustine hydrochloride, solid dispersions substantially free of degradants. Also provided are methods of producing and administering nitrogen mustards and in particular bendamustine hydrochloride solid dispersions substantially free of degradants. The pharmaceutical compositions can be used for any disease that is sensitive to treatment with bendamustine hydrochloride, such as neoplastic diseases.
    Type: Application
    Filed: March 4, 2015
    Publication date: September 17, 2015
    Inventor: Vasilios Voudouris
  • Bendamustine pharmaceutical compositions
    Patent number: 9061011
    Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: June 23, 2015
    Inventor: Vasilios Voudouris
  • Bendamustine Pharmaceutical Compositions
    Publication number: 20150065549
    Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: August 22, 2014
    Publication date: March 5, 2015
    Inventor: Vasilios Voudouris